Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sanofi
  6. Financials
    SAN   FR0000120578

SANOFI

(SAN)
  Report
Real-time Euronext Paris  -  07:09 2022-12-05 am EST
85.39 EUR   -0.44%
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/03J&J unit says does not intend to bid for Horizon Therapeutics
RE
12/02Weekly market update : One step forward, one step back
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 112 31098 877111 194107 561--
Enterprise Value (EV)1 128 816107 666121 177114 740110 292105 383
P/E ratio 40,0x8,01x17,8x14,6x12,2x11,2x
Yield 3,51%4,07%3,76%4,24%4,43%4,70%
Capitalization / Revenue 3,11x2,74x2,94x2,44x2,36x2,23x
EV / Revenue 3,57x2,99x3,21x2,61x2,42x2,19x
EV / EBITDA 10,8x9,41x9,95x7,79x7,28x6,53x
Price to Book 1,90x1,57x1,62x1,48x1,38x1,29x
Nbr of stocks (in thousands) 1 253 1781 256 3751 255 2931 254 060--
Reference price (EUR) 89,678,788,685,885,885,8
Announcement Date 02/06/202002/05/202102/04/2022---
1 EUR in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 36 12636 04137 76144 00645 62948 132
EBITDA1 11 90411 44312 18314 72415 14316 149
Operating profit (EBIT)1 9 7589 76210 71413 02013 46014 598
Operating Margin 27,0%27,1%28,4%29,6%29,5%30,3%
Pre-Tax Profit (EBT)1 2 82213 8047 7989 26611 04211 923
Net income1 2 80612 3146 2237 5118 7989 702
Net margin 7,77%34,2%16,5%17,1%19,3%20,2%
EPS2 2,249,824,975,887,027,69
Dividend per Share2 3,153,203,333,643,804,03
Announcement Date 02/06/202002/05/202102/04/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales1 9 9949 67410 11612 48211 17610 519
EBITDA1 2 6233 4263 1634 9313 454-
Operating profit (EBIT)1 2 2563 0652 7534 4982 7753 555
Operating Margin 22,6%31,7%27,2%36,0%24,8%33,8%
Pre-Tax Profit (EBT)1 1 3912 3491 3832 666--
Net income1 1 1312 0091 1752 0761 403-
Net margin 11,3%20,8%11,6%16,6%12,6%-
EPS2 0,901,610,941,661,26-
Dividend per Share ------
Announcement Date 02/04/202204/28/202207/28/202210/28/2022--
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 16 5068 7899 9837 1802 731-
Net Cash position1 -----2 177
Leverage (Debt / EBITDA) 1,39x0,77x0,82x0,49x0,18x-0,13x
Free Cash Flow1 5 9286 9828 0969 0639 83710 382
ROE (Net Profit / Equities) 12,7%12,1%12,5%13,6%13,5%13,7%
Shareholders' equity1 22 071102 18249 92755 04865 34470 858
ROA (Net Profit / Asset) 2,50%6,47%5,30%5,85%6,66%6,95%
Assets1 112 072190 442117 327128 329132 048139 621
Book Value Per Share2 47,250,354,858,162,266,3
Cash Flow per Share2 6,165,948,367,568,549,25
Capex1 1 8161 3292 0431 9032 0322 102
Capex / Sales 5,03%3,69%5,41%4,32%4,45%4,37%
Announcement Date 02/06/202002/05/202102/04/2022---
1 EUR in Million
2 EUR
Previous periodNext period
Estimates
Key data
Capitalization (EUR) 107 560 697 552
Capitalization (USD) 112 782 528 627
Net sales (EUR) 37 761 000 000
Net sales (USD) 39 594 212 016
Number of employees 95 442
Sales / Employee (EUR) 395 643
Sales / Employee (USD) 414 851
Free-Float 87,9%
Free-Float capitalization (EUR) 94 551 125 904
Free-Float capitalization (USD) 99 141 371 400
Avg. Exchange 20 sessions (EUR) 179 398 959
Avg. Exchange 20 sessions (USD) 188 108 377
Average Daily Capital Traded 0,17%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA